Karyopharm Therapeutics | KPTI - 资产

金融业

USD

USD 108.42M

现金及等价物

USD 60.54M

USD 1.48M

USD 103.15M

USD 92.06M

USD 299.23M

股息收益率

0

USD -17.84M

USD -26.2M

325

EPS每股收益

USD -2.22

股本和储备

USD -292.93M

USD 32.6M

债务利息支出

USD 12.62M

USD -0.15

USD 278.22M

USD 938.9M

USD -102.2M

USD 51.92M

USD -17.84M

普通股股本

USD 18.31M

USD -39.9M

USD 34.08M

销售和管理费用

USD 9.56M

USD 4.04M

贸易债权人

USD 4M

应收帐款人

USD 26.18M

	资产	更改		日
AbbVie	USD 136.46B		2.5B	2026-03
Abbott	USD 110.43B		23.72B	2026-03
Amgen	USD 92.5B		1.92B	2026-03
AstraZeneca	USD 114.02B		59M	2026-03
BioCryst Pharmaceuticals	USD 465.05M		49.11M	2026-03
Bristol-Myers Squibb	USD 86.48B		3.56B	2026-03
Eli Lilly	USD 116.58B		4.1B	2026-03
Enanta Pharmaceuticals	USD 329.5M		48.77M	2025-12
GlaxoSmithKline	GBP 62.87B		1.75B	2026-03
Incyte	USD 7.34B		381.14M	2026-03
J&J	USD 200.89B		1.68B	2026-03
Karyopharm Therapeutics	USD 108.42M		12.18M	2025-12
MacroGenics	USD 217.87M		38.97M	2026-03
Merck	USD 128.68B		8.18B	2026-03
Nektar Therapeutics	USD 280.41M		20.94M	2025-12
Novartis	USD 118.53B		7.58B	2026-03
Novartis	USD 110.95B		3.66B	2025-12
Pfizer	USD 207.62B		542M	2026-03
Regeneron Pharmaceuticals	USD 40.87B		310.1M	2026-03
Roche Holding	CHF 100.7B		5.94B	2025-12
Sangamo BioSciences	USD 97.56M		11.39M	2025-06
Takeda	JPY 15.45T		44.34B	2026-03
Tectonic Therapeutic	USD 246.58M		14.46M	2026-03
TG Therapeutics	USD 1.53B		465.58M	2026-03
Ultragenyx Pharmaceutical	USD 1.3B		236M	2026-03
Xencor	USD 736.85M		138.65M	2026-03